Redmile Group, LLC Allakos Inc. Transaction History

Redmile Group, LLC

$1.28 Billion
Q4 2024

A detailed history of Redmile Group, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 3,015,097 shares of ALLK stock, worth $874,378. This represents 0.29% of its overall portfolio holdings.

Number of Shares

3,015,097

Previous 3,077,828 2.04%

Holding current value

$874,378

Previous $2 Million 82.4%

% of portfolio

0.29%

Previous 0.13%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.62 - $1.5 $38,893 - $94,096	-62,731 Reduced 2.04%	3,015,097 $3.65 Million
Q2 2024 Aug 14, 2024	SELL	$1.0 - $1.45 $373,248 - $541,209	-373,248 Reduced 10.82%	3,077,828 $3.08 Million
Q1 2024 May 15, 2024	SELL	$1.02 - $3.23 $223,758 - $708,568	-219,371 Reduced 5.98%	3,451,076 $4.35 Million
Q4 2023 Feb 14, 2024	BUY	$1.72 - $3.18 $2.39 Million - $4.41 Million	1,386,853 Added 60.73%	3,670,447 $10 Million
Q2 2023 Aug 14, 2023	SELL	$3.6 - $5.25 $9,298 - $13,560	-2,583 Reduced 0.11%	2,283,594 $9.96 Million
Q1 2023 May 15, 2023	SELL	$4.3 - $8.27 $1.11 Million - $2.14 Million	-259,098 Reduced 10.18%	2,286,177 $10.2 Million
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $38,220 - $90,258	-14,700 Reduced 0.57%	2,545,275 $7.97 Million
Q1 2022 May 16, 2022	BUY	$5.08 - $9.81 $2.45 Million - $4.73 Million	482,100 Added 23.2%	2,559,975 $14.6 Million
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $461,024 - $6.03 Million	-53,921 Reduced 2.53%	2,077,875 $20.3 Million
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $6.52 Million - $9.41 Million	-85,200 Reduced 3.84%	2,131,796 $226 Million
Q2 2021 Aug 16, 2021	SELL	$85.37 - $114.1 $17.3 Million - $23.1 Million	-202,422 Reduced 8.37%	2,216,996 $189 Million
Q1 2021 May 17, 2021	SELL	$109.73 - $153.66 $27.2 Million - $38.1 Million	-248,033 Reduced 9.3%	2,419,418 $278 Million
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $19.2 Million - $36.9 Million	241,891 Added 9.97%	2,667,451 $373 Million
Q3 2020 Nov 16, 2020	SELL	$66.43 - $90.99 $12.9 Million - $17.6 Million	-193,520 Reduced 7.39%	2,425,560 $198 Million
Q2 2020 Aug 14, 2020	SELL	$44.04 - $80.69 $15.8 Million - $28.9 Million	-357,848 Reduced 12.02%	2,619,080 $188 Million
Q1 2020 May 15, 2020	SELL	$44.49 - $93.39 $2.52 Million - $5.29 Million	-56,598 Reduced 1.87%	2,976,928 $132 Million
Q4 2019 Feb 14, 2020	SELL	$66.49 - $137.73 $2.9 Million - $6.01 Million	-43,602 Reduced 1.42%	3,033,526 $289 Million
Q3 2019 Nov 14, 2019	BUY	$31.0 - $89.73 $24.1 Million - $69.7 Million	776,827 Added 33.77%	3,077,128 $242 Million
Q2 2019 Aug 14, 2019	BUY	$36.0 - $44.73 $16.8 Million - $20.8 Million	465,891 Added 25.4%	2,300,301 $99.7 Million
Q1 2019 May 15, 2019	BUY	$33.79 - $51.99 $4.59 Million - $7.06 Million	135,762 Added 7.99%	1,834,410 $74.3 Million
Q4 2018 Feb 14, 2019	BUY	$31.59 - $62.65 $7.54 Million - $15 Million	238,756 Added 16.35%	1,698,648 $88.8 Million
Q3 2018 Nov 14, 2018	BUY	$31.25 - $47.64 $45.6 Million - $69.5 Million	1,459,892 New	1,459,892 $65.7 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

68.8M

Call Options Held

20.9K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $24.6M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account

Redmile Group, LLC Allakos Inc. Transaction History